% YoY and 22% QoQ from a net gain in foreign exchange. SIM & Device sales reported at Bt39,476mn, growing 8.0%YoY from a higher sale volume of iPhone14 (all models) compared to last year’s sale of
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
product quality (the company has been awarded ISO 13485, the Quality Management System for Medical Device Industry), which is an important tool in the competition and expansion of the market in the future
name="viewport">` in some cases. @at-root { @-ms-viewport { width: device-width; } } // stylelint-disable selector-list-comma-newline-after // Shim for "new" HTML5 structural elements to display
Interest Rate: EIR) to calculate the income that the Management Discussion and Analysis (MD&A) 2019 Page 6/6 Company can recognize in each period. The Company was on the period of evaluation the impact on
evaluation as well as negotiation and agreement between the Parties. The Company has taken seriously into account of the business plan and the Company’s interest and benefit. 4. Calculation of the size of the
1,447.32 million as of December 31, 2018 due to the decrease of other components of Shareholders’ Equity – the premium of asset evaluation. Kindly be informed accordingly, 5 Yours sincerely, East Coast
shareholder. This accounted 75.35 % in the third quarter of 2017. The company has not received a written valuation by an independent evaluation. So it is not yet recorded profit from changes to the investment